Walleye Capital’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $151K | Sell |
129,867
-211,521
| -62% | -$245K | ﹤0.01% | 1456 |
|
2025
Q1 | $543K | Buy |
341,388
+147,679
| +76% | +$235K | ﹤0.01% | 1050 |
|
2024
Q4 | $587K | Buy |
+193,709
| New | +$587K | ﹤0.01% | 1113 |
|
2024
Q3 | – | Sell |
-22,021
| Closed | -$90.1K | – | 2916 |
|
2024
Q2 | $90.1K | Buy |
+22,021
| New | +$90.1K | ﹤0.01% | 2081 |
|
2022
Q4 | – | Sell |
-85,529
| Closed | -$1.85M | – | 2680 |
|
2022
Q3 | $1.85M | Buy |
+85,529
| New | +$1.85M | 0.04% | 485 |
|
2022
Q2 | – | Sell |
-20,455
| Closed | -$944K | – | 2701 |
|
2022
Q1 | $944K | Buy |
20,455
+7,117
| +53% | +$328K | 0.03% | 645 |
|
2021
Q4 | $1.12M | Buy |
+13,338
| New | +$1.12M | 0.03% | 508 |
|